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Edited by Michael R. BubbAbstract Migration, proliferation and death of vascular smooth
muscle cells (VSMC) are important events in vascular pathology
regulated by heparan sulfate proteoglycans and hence potentially
by cell surface HS 6-O-endosulfatase1 (sulf1). Sulf1 mRNA
expression was increased in cultured VSMC compared to rat
aorta. Furthermore, adenovirus mediated overexpression of quail
sulf1 decreased adhesion, and increased proliferation and apop-
tosis of VSMC. Overexpression of a dominant negative variant
also decreased adhesion of VSMC and increased proliferation,
apoptosis, migration and chemotaxis of VSMC. Our results im-
ply that only normal levels of 6-O-sulfation maintained by sulf1
are optimal for several functions of VSMC.
 2005 Federation of European Biochemical Societies. Published
by Elsevier B.V. All rights reserved.
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Thickening of the inner intimal layer of arteries is an impor-
tant component of atherosclerosis and the vascular response to
injury, for example after balloon injury or in vein grafts. If the
lumen is narrowed excessively it can lead to distal ischemia
resulting in clinical symptoms such as angina pectoris and
intermittent claudication. Intimal thickening involves accumu-
lation of vascular smooth muscle cells (VSMC) and their asso-
ciated extracellular matrix (ECM) [1]. VSMC are normally
conﬁned to the medial layer where they are maintained quies-
cent and contractile by interactions with their surrounding
basement membrane, which contains predominately collagen
IV, laminin and heparan sulfate proteoglycans (HSPGs) [2].
The relationship between HSPGs and VSMC behavior is com-
plex. For example, HSPGs are an essential component of the
low aﬃnity receptors that in part mediate FGF-2-induced
VSMC proliferation [3]. On the other hand, HSPGs have a
number of inhibitory actions. They sequester growth factors,
including FGF-2, which would otherwise activate VSMCs.
They also interact directly with cell surface receptors, through
which they inhibit migration and proliferation of VSMCs and
promote diﬀerentiation towards a quiescent state [4–6].
Remodeling of HSPGs occurs during response to vascular in-
jury and may promote neointima formation. For example,
heparin lyase activity is increased 3–14 days after balloon cath-*Corresponding author. Fax: +44 0 1179283581.
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phage-derived lysosomal heparin lyases removed all of the
35S labeled HS and induced a more proliferative VSMC pheno-
type in culture [8].
The highly heterogeneous HS glycosaminoglycan (HS)
chains of HSPG determine ligand binding and hence function.
They contain N-sulfated, acetylated and unsubstituted gluco-
samine and O-sulfate groups at characteristic positions [9].
Previous work suggests that the level of 6-O-sulfation of HS
chains, in particular, can inﬂuence the function of HSPGs
[10,11]. Consistent with this, a cell surface HS 6-O-endosulfa-
tase with a preference towards trisulfated iduronic acid 2S-glu-
cosamine-NS6S disaccharide units was recently cloned from
quail embryos and shown to have a role in development of
the skeletal muscle system [12]. Rat, human and mouse ortho-
logs (sulf1, sulf2) were subsequently cloned and the quail en-
zyme relates closely to sulf1 [13–15]. These sulfatases were
implicated in tumor invasion and metastasis [13,16], which
has mechanistic similarities with invasion of VSMC into the in-
tima. We therefore questioned whether Sulf1 could regulate
the level of HS 6-O-sulfation and thereby aﬀect the behavior
of VSMC. As a ﬁrst step, we prepared adenoviruses to overex-
press wild-type and a dominant negative variant of sulf1 and
investigated their eﬀects on VSMC behavior in culture.2. Materials and methods
2.1. Semi-quantitative RT-PCR analysis
Total RNA was extracted from isolated VSMCs and rat aortic seg-
ments using a ﬁbrous tissue RNA extraction (Qiagen). First-strand
cDNA was synthesized by random priming using the ﬁrst-strand syn-
thesis kit (ProStar, Stratagene). Semi-quantitative PCR was performed
using primers for rat sulf1 [13] (forward, 5 0-CAAGTGTTACCG-
CCAAGGAG-3 0, and reverse, 5 0-TGTAGGCCTTGTGGTCCTTC-
3 0); 18S (forward 5 0-CTCGATGCTCTTAGCTGAGT-3 0 and reverse
5 0-CTT CAA ACC TCC GAC TTT CG-3 0) for various numbers of cy-
cles to ensure that reactions did not reach saturation. Products were
separated on agarose gels and analyzed by densitometry using Alpha-
Image analysis software (AlphaInnotech Corporation). Representative
bands were excised, eluted (Qiagen) and sequenced (Lark technologies)
to conﬁrm their identity.
2.2. Construction of recombinant adenoviral vectors
Previously described plasmids containing cDNA coding for Qsulf1
wild-type and a dominant negative (CC89,90AA) form and a carboxy-
terminal myc tag were obtained [12]. The coding sequences were excised
and subcloned into a commercially available shuttle vector, pDC 515
(Microbix Biosystems Canada), downstream from the mouse cytomeg-
alovirus promoter. Replication-deﬁcient adenoviruses were gener-
ated by site-speciﬁc FLP-mediated recombination of the cotransfectedblished by Elsevier B.V. All rights reserved.
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CsCl banded, and titrated as previously described [17].
2.3. Culture and infection of SMC
Isolated VSMCs were prepared from the thoracic aorta of male
Sprague–Dawley rats using a modiﬁcation of the explant technique de-
scribed previously [18]. VSMC of passages 2–7 were plated at a density
of 4 · 104 cells/cm2 and infected where indicated with 300 plaque-form-
ing units (pfu) of adenovirus/cell. A previously described adenovirus
expressing b-galactosidase [17] was used to control for the non-speciﬁc
eﬀects of viral infection.
2.4. Western blotting
Cells were lyzed in 50 mM Tris–HCl, pH 6.8, 10% glycerol, 1% SDS.
Lysates were analyzed for protein content (Micro BCA assay kit,
Pierce) and 20–60 lg of reduced protein were separated by polyacryl-
amide gel electrophoresis and transferred to PVDF membrane (Bio-
Rad). Membranes were blocked with PBS, pH 7.4 containing 5% milk
powder and incubated with antibodies to the myc tag (9E10, Santa
Cruz), phospho p44 and p42 ERK1/2 and total ERK1/2 (Cell Signal-
ing) or phospho FAKY397 (Upstate) for 3 h at room temperature.
Bound antibodies were detected using horseradish peroxidase-conju-
gated (HRP) secondary antibodies (Dako). Peroxidase activity was de-
tected using enhanced chemoluminescence (Amersham Biosciences).
Blots were stripped using Re-Blot (Chemicon).
2.5. Determination of cell surface 6-O-sulfate content
1 · 104 VSMC were plated in 96 well plates, infected at 300 pfu/cell
of the adenovirus. After 48 h, the cells were washed twice with PBS,
ﬁxed with 4% formaldehyde/PBS for 10 min at room temperature,
blocked in 1% BSA for 30 min and incubated with a 1:200 dilution
of 10E4 antibody that recognizes the HS 6-O-sulfated glucosamine res-
idues known to be hydrolyzed by sulf1 [11] for 1 h, mouse IgG at the
same concentration was used as negative control. After 3 washes in
PBS, a 1:200 dilution of goat anti-mouse HRP was added, incubated
for 30 min, washed 3 times in PBS and incubated for up to 10 min with
2,2 0-azino-di[3-ethylbenzthiazoline sulfonate] (Roche, Lewes, East Sus-
sex, UK) and the absorbance read at 405 nm. The absorbance units/
cell is expressed as a percentage of the b-gal control.
2.6. Immunoﬂuorescence
VSMC cultured and infected on coverslips for 48 h were ﬁxed with
ice-cold 4% paraformaldehyde/PBS for 20 min at 4 C. After incubation
in 1% Triton X-100 at 4 C for 5 min, VSMCs were incubated with 4%
BSA/PBS at room temperature for 5 min followed by mouse 10E4 anti-
body at 10 lg/mLormouse IgG (Sigma) in 1%BSA/PBS for 2 h at room
temperature. VSMCs were then incubated for 45 min with biotinylated
goat anti-mouse IgG (Dako) diluted 1:200 in 1% BSA/PBS and then for
30 min with extravidin-FITC diluted 1:200 in 1% BSA/PBS.
2.7. Proliferation
Cell numbers were counted 48 h after infection. VSMC proliferation
was quantiﬁed by incorporation of 10 lM bromodeoxyuridine (BrdU)
for 12 h at 36 h after infection. Incorporated BrdU was detected as pre-
viously described [19].
2.8. Apoptosis measurements
Apoptosis was analyzed at 48 h after infection by immuno-ﬂuores-
cent detection of cleaved caspase-3 and by in situ end labeling (ISEL)
as previously described [20].
2.9. Migration
VSMC migration was analyzed 48 h after infection using modiﬁed
Boyden chambers as previously described [21]. Brieﬂy, infected VSMCs
were detached using 0.02% EDTA/PBS and placed at 5 · 104 cells per
well in the chambers containing uncoated membranes or membranes
coated with 0.75 mg/cm2 Matrigel (Becton Dickinson Labware).
2.10. Cell adhesion assay
VSCM infected for 48 h were detached using 0.02% PBS/EDTA,
resuspended in DMEM supplemented with 10% FCS and allowed to
adhere to uncoated wells at 37 C for 45 min and 3 h. The wells werewashed with PBS to remove unattached cells, ﬁxed in formalin, stained
with 1% aqueous toluidine blue and quantiﬁed spectrophotometrically
[22]. Results were expressed as percentage of cells adherent at 3 h.
2.11. Statistics
Experiments were performed at least 3 times with diﬀerent VSMCs
(n indicates the times the experiment was repeated). Data were ana-
lyzed using a two-tailed paired t test; signiﬁcant diﬀerences were taken
if P < 0.05.
3. Results
3.1. Expression of endogenous sulf1 and overexpression Qsulf1
and DNQsulf1 in rat VSMC
We used semi-quantitative RT-PCR to measure endogenous
sulf1 mRNA in cultured rat VSMCs and aorta. Although rat
sulf1 mRNA was present in rat aortas, signiﬁcantly higher lev-
els were detected in cultured aortic VSMC (Fig. 1A). This indi-
cates that the expression of sulf1 is increased in the highly
proliferative cultured VSMCs compared to the relatively quies-
cent VSMCs in the rat aorta.
To examine the function of sulf1 in VSMCs, we constructed
recombinant adenoviruses that contained the entire coding se-
quence of the quail wild-type enzyme downstream of a mouse
CMV promoter (Qsulf1). We also constructed viruses with the
(CC89,90AA) variant, which has been shown previously [12] to
be inactive and possess dominant negative properties (DNQ-
sulf1). Both transgenes were tagged with myc. Western blots
using an anti-myc antibody demonstrated that infection with
adenoviruses resulted in the overexpression of Qsulf1 and
DNQsulf1, respectively (Fig 1B). The majority of the recombi-
nant sulfatases were retained within the cell, with less than 1%
secreted into the medium (Fig. 1B).
Measurement of catalytic activity of sulf1 towards extracel-
lular substrates is complicated by the presence of much larger
amounts of lysosomal sulfatases in cell homogenates. We
therefore designed a whole cell ELISA assay based on immu-
noreactivity to antibody 10E4, the epitope of which includes
the HS 6-O-sulfated glucosamine residues known to be hydro-
lyzed by sulf1 [11]. Immunocytochemistry with 10E4 showed
activity particularly at the margins between cells. Immunoreac-
tivity appeared decreased in Qsulf1 overexpressing cells and in-
creased in cells expressing DNQsulf1 compared to control
VSMC overexpressing b-galactosidase (Fig. 2A). Consistent
with these observations, overexpression of Qsulf1 signiﬁcantly
decreased immunoreactivity to antibody 10E4 detected using a
whole-cell ELISA assay (Fig. 2B). The overall reduction was
only approximately 10%, which suggests either that overex-
pressed Qsulf1 was inadequate to hydrolyze all 6-O-sulfated
glucosamines or, more likely, that the antibody also recognized
other sugars. Indeed 10E4 is known from other studies to also
bind strongly to disaccharides containing terminal non-sul-
fated hexuronoic acid and unsubstituted N-glucosamine. [23].
DNQsulf1 signiﬁcantly increased 10E4 immunoreactivity by
35% compared to control cells, consistent with it behaving as
a dominant negative inhibitor of sulf1.
3.2. Adhesion, proliferation and apoptosis of VSMC
Cell adhesion is known to inﬂuence proliferation, migration
and death of VSMC. Overexpression of either Qsulf1 or DNQ-
sulf1 impaired adhesion of rat VSMC to tissue culture wells
(Fig. 3A). This implies that sulf1 contributes to maintaining
a level of HS 6-O-sulfation that appears optimal for adhesion.
Fig. 1. Expression of endogenous and recombinant sulf1 in VSMC. (A) Semiquantitative RT-PCR analysis for sulf1 was performed on total RNA
from rat aorta or cultured VSMC as shown and expression was normalized to18S rRNA. A representative gel is shown, PCR was performed for 19
cycles for 18S rRNA and 29 for sulf1. *P < 0.05, n = 3. (B) VSMCs were infected with either control adenovirus (b-Gal, lanes 1 and 4), wild-type
Qsulf1 expressing adenovirus (lanes 2 and 5) or DNQsulf1 (lanes 3 and 6). Cell lysate and conditioned medium were analyzed for myc-tag expression
by Western blotting 48 h after infection. Blots were overexposed so as to detect the proteins in the conditioned medium.
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creased VSMC proliferation measured by BrdU incorporation
94% and 72%, respectively, compared to control cells over-
expressing b-galactosidase (Fig. 3B). Interestingly, increased
BrdU incorporation was not accompanied by increased cell
counts in VSMC overexpressing Qsulf1 compared to b-galac-
tosidase, while cultures overexpressing DNQsulf1 had signiﬁ-
cantly decreased cell numbers relative to both other
treatments (Fig. 3C). To explain this discrepancy, we investi-
gated the levels of apoptotic cell death. DNA fragmentation
measured by ISEL revealed that VSMC overexpressing Qsulf1
had 2.8-fold higher levels of apoptotic cell death than b-galac-
tosidase overexpressing VSMC (Fig. 4A), while cells over-
expressing DNQsulf1 showed 11.5-fold higher levels.
Immunostaining of VSMC for cleaved caspase3, a downstream
executioner of the apoptosis cascade, conﬁrmed that overex-
pression of Qsulf1 signiﬁcantly increased apoptosis and that
this was further increased by DNQsulf1 (Fig. 4B). Clearly in-
creased cell death caused by Qsulf1 overexpression nulliﬁed
the eﬀects on cell proliferation while death caused by DNQ-
sulf1 overexpression more than overcame the increase in pro-
liferation.
3.3. Migration of VSMC
VSMC migration also plays a fundamental role in intimal
thickening and we therefore investigated the eﬀect of altering
HS 6-O-sulfation on chemotaxis and invasion. Overexpressing
Qsulf1 did not aﬀect chemotaxis of VSMC through uncoated
wells or invasion through reconstituted basement membranes
(Matrigel) relative to b-galactosidase controls (Fig. 5A
and B). On the other hand increasing 6-O-sulfation by over-
expressing DNQsulf1 signiﬁcantly increased invasion through
(Matrigel) and chemotaxis compared to control cells
(Fig. 5A and B).3.4. Eﬀects on ERK1/2 and Focal adhesion kinase (FAK)
phosphorylation
To gain a ﬁrst insight into the mechanisms underlying the ef-
fects of sulf1, we measured ERK1/2 phosphorylation and total
ERK levels by Western blotting under conditions similar to
those used for the proliferation measurements (Fig. 6A). Both
Qsulf1 and DNQsulf1 increased ERK phosphorylation 2.8–
7.4-fold in quiescent VSMC and 1.5–3.2-fold after 2 h and
1.2–3.1-fold after 4 h of serum stimulation (either treatment
P < 0.05 vs. b-gal, Kruskal–Wallis test). By contrast when we
measured FAK phosphorylation under conditions similar to
those used for the adhesion measurements there was no eﬀect
of either treatment (Fig. 6B).4. Discussion
There is a wealth of evidence that HSPGs regulate the
behavior of VSMC. For example addition of HSPGs, glycos-
aminoglycans derived from them or indeed heparin profoundly
inhibit VSMC proliferation [4–6]. Conversely, transgenic mice
with HS-deﬁcient perlecan display increased VSMC prolifera-
tion and intima formation [24]. As detailed in Section 1, the
status of 6-O-sulfation inﬂuences function of HSPGs. How-
ever, endogenous 6-O-sulfatases have only recently been
cloned and hence our study is the ﬁrst to demonstrate sulf1
expression in VSMC. Moreover, we demonstrated upregula-
tion of sulf1 mRNA levels between intact aortas and VSMC
in culture. It will be valuable to conﬁrm this regulation at
the level of protein should suitable antibodies become avail-
able. Many previous studies have compared gene expression
in aortas as a model for quiescent cells and in cultured cells
as a model for the cells involved in neointima formation [25].
This is valid because cultured VSMC share phenotypic charac-
Fig. 2. Analysis of 6-O-sulfate glucosamine using antibody 10E4.
VSMCs were infected with either control adenovirus (Ad:bGal), or
adenovirus expressing wild-type Qsulf1 or DNQsulf1 as indicated. (A)
By immmunoﬂuorescence. (B) By ELISA, n = 4, *P < 0.05.
Fig. 3. Measurement cell adhesion and proliferation and apoptosis.
VSMC were infected with adenovirus expressing b-galactosidase,
Qsulf1 or DNQsulf1 for 48 h. (A) Infected VSMC were placed in 96-
well plates (1.5 · 104/well) and allowed to attach for 45 m and 3 h.
Following ﬁxation and toluidine staining, absorbance at 595 nm was
measured and percentage of cells adherent at 45 m vs. 3 h was
calculated. (B) VSMC were labeled with BrdU for the last 12 h and
then immunostained. (C) VSMC numbers by cell counting. *P < 0.05,
n = 3.
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proliferate in response to serum many times faster than VSMC
in intact aortas [18]. Interestingly previous studies demon-
strated upregulation HSPG core protein genes in proliferating
rat VSMC. For example, syndecan mRNAs increase beginning
at day 2 after rat carotid balloon injury and perlecan tran-
scripts increase after a weeks lag to a peak after 2–4 weeks
[26]. By contrast to sulf1, N-deacetylase/N-sulfotransferase,
the enzyme responsible for the initiation of 6-O-sulfation of
the disaccharide units, is downregulated in proliferating
VSMC compared to uninjured arteries [27]. Increased sulfation
[27] and decreased sulfatase (our present data) both imply that
higher levels of 6-O-sulfation correlate with quiescence of
VSMC.
Using overexpression of Qsulf1 to reduce and DNQsulf1 to
increase 6-O-sulfation in cultured VSMC, we are also the ﬁrst
to demonstrate that sulf1 regulates the major properties of
VSMC, namely adhesion, proliferation, apoptosis and migra-
tion. Interestingly, both Qsulf1 and DNQsulf1 overexpressiondecreased adhesion and increased proliferation and apoptosis
of VSMC. Our results imply that only the normal physiolog-
ical levels of 6-O-sulfation maintained by sulf1 mediate opti-
mal levels of adhesion. Such adhesion appears to partially
inhibit proliferation but has a major beneﬁt in terms of avoid-
ing apoptosis of VSMC. The relationship between cell adhe-
sion and migration is also a complex one. Too great
adhesion can physically retard migration but insuﬃcient adhe-
sion can result in failure to gain traction and therefore also in-
hibit migration. In our experiments, reducing adhesion by
overexpressing sulf1 had little eﬀect on migration but reducing
adhesion further with DNQsulf1 signiﬁcantly increased migra-
tion. These results imply that the normal physiological levels
of 6-O-sulfation maintained by sulf1 partly restrict migration.
The mechanisms responsible for the eﬀects of sulf1 on
VSMC are unknown. Qsulf1-mediated remodeling of cell sur-
face HS was previously shown to promote proliferation
through Wnt signaling [11,12]. However, we could detect no
diﬀerence in b-catenin nuclear localization in VSMC infected
with Qsulf1, DNQsulf1 or b-galactosidase (results not shown).
We did however detect an equivalent stimulatory eﬀect of
Qsulf1 and DNQsulf1 on ERK phosphorylation that most
likely contributed to their stimulatory eﬀects on VSMC prolif-
eration. By contrast we found no eﬀect on FAK phosphoryla-
tion, which shows some speciﬁcity in the eﬀects of Qsulf
manipulations. Previous work suggests that Sulf1 could be ac-
tive either in the Golgi apparatus as well as the cell surface.
Moreover shedding of surface sulf1 occurs in CHO [15] and
could therefore lead to a bystander eﬀect. However, this was
Fig. 5. Measurement of VSMC migration applying onto membranes.
(A) Chemotaxis was analyzed using uncoated membranes. (B) Inva-
sion was analyzed using Matrigel coated membranes. *P < 0.05, n = 3.
Fig. 6. Phosphorylation of ERK1/2 and FAK. (A) VSMC were
infected with adenovirus for 30 h, quiesed in serum-free DMEM with
0.1% lactalbumin for 18 h, then 10% serum was added back for the
times shown. 60 lg of total protein per lane was probed for phospho
ERK, stripped and probed for total ERK. (B) VSMC were infected
with adenovirus for 48 h, detached, rested at 2.5 · 105/ml in DMEM
containing 10% serum plus 10 mM HEPES, pH 7.4, at 25 C for 3 h
and then adhered for the times shown. Total cell lysates were probed
for phospho FAK, stripped and probed for GAPDH. Representative
results of 2 separate experiments are shown.
Fig. 4. Measurement of apoptosis. VSMC were infected with adeno-
virus expressing b-galactosidase, Qsulf1 or DNQsulf1 as indicated for
48 h. (A) Apoptotic cell death analyzed by ISEL. (B) Apoptotic cell
death analyzed by immunoﬂuorescence of cleaved caspase-3. (C) A
representative micrograph showing caspase-3 green and nuclei blue.
*P < 0.05, n = 3.
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according to our studies in VSMC.
Taken together, our results provide the ﬁrst evidence for a
role of sulf1 in regulating the behavior of VSMC. Future stud-
ies beyond the scope of this paper using transgenic and knock-out animals are now justiﬁed to investigate the role of sulf1 in
neointima formation in vivo.
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